✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Laurus Labs Ltd

Common Name
Laurus Labs
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,167
Ticker
LAURUSLABS
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Laurus Labs Ltd. is a prominent pharmaceutical company engaged in the manufacturing and commercialization of high-quality generic Active Pharmaceutical Ingredients (APIs), formulations, and specialty ...

Laurus Labs's Financial Statements Preview

Below are the financial statements of Laurus Labs, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of INR
2025
2024
Income
Revenue from operations
55,539.6a
50,408.3a
Other income
599.3a
207.3a
Total income
56,138.9a
50,615.6a
Expenses
Cost of materials consumed
-24,285.5a
-24,223.8a
Purchase of traded goods
-1,053.6a
-1,109.2a
Changes in inventories of finished goods, work-in-progress and stock-in-trade
-559.3a
-1,008.8a
Employee benefits expense
-7,195.2a
-6,399.3a
Other expenses
-13,011.8a
-11,909.8a
Total expenses
-44,986.8a
-42,633.3a
Earnings before interest, tax, depreciation and amortisation (EBITDA)
11,152.1a
7,982.3a
Depreciation and amortisation
-4,300.9a
-3,845.8a
Finance income
-151.7a
-56.1a
Finance costs
-2,160a
-1,829a
Profit before tax
4,842.9a
2,363.6a
Tax expense
Current tax
-1,569a
-931.1a
Deferred tax
-270.2a
-249.6a
Total tax expense
-1,298.8a
-681.5a
Profit for the year before share of profit/(loss) from associates and joint venture
3,544.1a
1,682.1a
Share of profit/(loss) from associates and joint venture, net of tax
39.3a
-59.4a
Profit for the year after share of profit/(loss) from associates and joint venture
3,583.4a
1,622.7a
Profit for the year attributable to
Equity holders of the parent company
3,583.2a
1,605.5a
Non-controlling interests
0.2a
17.2a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Laurus Labs’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Laurus Labs's Integrated Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?